NSE: SHARDACROP | BSE: 538666

Strong Performer, Under Radar

Download real time

820.00 0.00 (0.00%)

36.78% Fall from 52W High

192.0K NSE+BSE Volume

NSE 31 Jul, 2026 1:32 PM (IST)

7,398.1

Market Cap

High in industry

Beta 1Year

Very High Volatility

Margin Decline

Sharda Crop's Q1 EBITDA margin drops 450 bps YoY due to higher inventory, staff & finance costs See details

Sharda Cropchem Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SHARDACROP, BSE:538666 Sharda Cropchem Ltd.

Search Inside the pdf :

Sharda Cropchem Ltd.

18 May 2026

Agrochemical recovery and pricing power keep long-term outlook intact

Buy: Sharda Cropchem Ltd.

Target

Khambatta Securities

Sharda Cropchem Limited (SCL) ended the year FY26 on high note with revenue rising 21.9% y-o-y to Rs. 5,267.6 crore driven by volume growth of 13.4% y-o-y and favourable forex impact.

Sharda Cropchem has lost -20.84% in the last 6 Months

Sharda Cropchem Ltd.

02 Feb 2026

SHARDA CROPCHEM LIMITED

Buy: Sharda Cropchem Ltd.

Geojit BNP Paribas

The RSI has surged into the bullish zone near 65, indicating strong momentum; while this suggests elevated activity, it also reflects renewed buying strength following the breakout. The MACD has turned positive, with a bullish crossover and a rising histogram, confirming...

Sharda Cropchem has lost -27.00% in the last 1 Year

Sharda Cropchem Ltd.

02 Feb 2026

Registration pipeline and market recovery support outlook

Buy: Sharda Cropchem Ltd.

Target

Khambatta Securities

Sharda Cropchem Limited (SCL) reported a solid revenue growth of 38.7% y-o-y in 3Q FY26, reaching Rs 1,288.8 crore. This growth was primarily driven by volume growth of 14.4% and change in the product mix.

Sharda Cropchem has lost -28.73% in the last 3 Months

Sharda Cropchem Ltd.

30 Jan 2026, 12:00AM

Continued outperformance momentum to sustain; maintain BUY

Buy: Sharda Cropchem Ltd.

Target

Anand Rathi

Sharda Cropchem continued to outperform in Q3FY26, aided by healthy, 14% y/y volume growth, positive product-mix and favourable forex and market-share gain in its key regions.

Sharda Cropchem has lost -28.73% in the last 3 Months

Sharda Cropchem Ltd.

05 Dec 2025

Factory-to-Farmer

buy: Sharda Cropchem Ltd.

FundsIndia

Edge: High-entry-barrier regulatory portfolio + scalable global network

Sharda Cropchem Ltd. is trading below all available SMAs

Sharda Cropchem Ltd.

04 Nov 2025

Inventory normalization across distribution channels support outlook

Buy: Sharda Cropchem Ltd.

Target

Khambatta Securities

SCL reported a robust performance in 2Q FY26, driven by strong volume growth and margin expansion. The Company remains optimistic about a gradual recovery in the global agrochemical market, noting that inventories have normalized across distribution channels.

Sharda Cropchem Ltd. is trading below all available SMAs

Sharda Cropchem Ltd.

01 Nov 2025

Yet another solid quarter; momentum to persist; retaining a Buy

Buy: Sharda Cropchem Ltd.

Anand Rathi

Healthy, 35% y/y, volume growth and market-share gains in its key regions drove Sharda Cropchem’s Q2 results. Growth improved on better demand particularly in NAFTA and Europe coupled with near complete de-stocking across major regions.

Sharda Cropchem has lost -20.84% in the last 6 Months

Sharda Cropchem Ltd.

21 Aug 2025

Global agrochemical recovery fuels positive outlook

Buy: Sharda Cropchem Ltd.

Recommendation Target

Khambatta Securities

Sharda Cropchem Limited (SCL) reported a 25% y-o-y increase in total revenue for 1Q FY26, reaching Rs 984.8 crore.

Sharda Cropchem has lost -28.73% in the last 3 Months

Sharda Cropchem Ltd.

28 Jul 2025

Solid start to FY26; momentum to continue; retaining a Buy

Buy: Sharda Cropchem Ltd.

Target

Anand Rathi

Healthy, 13% y/y, volume growth and market-share gains in its key regions drove Sharda Cropchem’s Q1 results. Growth improved on the back of better demand scenario particularly in Europe and a near complete destocking across major regions.

Sharda Cropchem Ltd. is trading below all available SMAs

Is Sharda Cropchem Ltd. worth buying?

186 Votes:

Buy 80.11%

Sell 11.83%

Hold 8.06%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf